Product Center
Products Center
Jiuhua Huayuan Pharmaceutical was approved to set up a national postdoctoral research station
Release time:
2025-03-07 00:00
Source:
Recently, Jiuhua Huayuan Pharmaceutical Co., Ltd. has successfully been approved by the Ministry of Human Resources and Social Security and the National Postdoctoral Management Committee to establish a national postdoctoral research workstation. This achievement has attracted significant attention in the pharmaceutical industry, marking a major breakthrough in technological innovation and talent development at Jiuhua Huayuan Pharmaceutical. It also signifies that the company has reached new heights in pharmaceutical R&D innovation.
As a high-tech company dedicated to the research, development, production, and sales of pharmaceuticals, Jiuhua Huayuan Pharmaceutical has consistently adhered to an innovation-driven development strategy. As early as 2018, the company made forward-looking moves in the construction of scientific research platforms, pioneering the establishment of a provincial postdoctoral workstation. Through collaboration among industry, academia, and research, the company has achieved several breakthroughs in the R&D of traditional Chinese medicine and chemical drugs, as well as in the artificial cultivation of Bai Rui Cao (a traditional Chinese herb).
In recent years, the company has significantly increased its R&D investment, allocating a significant portion of its revenue to technological innovation. It has also assembled a high-level R&D team that spans multiple disciplines, including pharmacy, medicine, and chemistry. Following this upgrade to a national-level postdoctoral research workstation, Jiuhua Huayuan Pharmaceutical will focus on cutting-edge areas such as innovative drug development and advanced pharmaceutical processes. The company aims to accelerate the transformation of scientific and technological achievements, providing core momentum for its high-quality development.
The person in charge of the company said that the workstation will become an important platform to attract high-level talents. In the future, it will further deepen cooperation with universities and research institutions, gather global innovation resources, strive to produce more research results with international influence, and contribute to the upgrading of China's pharmaceutical industry.
Industry experts pointed out that the establishment of national post-doctoral workstations not only highlights the leading position of enterprises in industry technology, but also injects strong vitality into talent gathering and technological innovation in local pharmaceutical industry.
